Laurus Labs Ltd 540222
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 439.95
- Day Range
- INR 438.05–444.00
- 52-Week Range
- INR 307.35–470.90
- Bid/Ask
- INR 443.15 / INR 443.95
- Market Cap
- INR 239.03 Bil
- Volume/Avg
- 1,107 / 77,319
Key Statistics
- Price/Earnings (Normalized)
- 143.47
- Price/Sales
- 4.64
- Dividend Yield (Trailing)
- 0.18%
- Dividend Yield (Forward)
- 0.18%
- Total Yield
- 0.18%
Company Profile
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceuticals ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. It generates revenue from the sale of API, Intermediates and Formulations, Contract research services and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 5,753
- Website
- https://www.lauruslabs.com
Comparables
Valuation
|
Metric
|
540222
|
533573
|
506690
|
|---|---|---|---|
Price/Earnings (Normalized) | 143.47 | 32.34 | — |
Price/Book Value | 5.68 | 3.92 | 1.59 |
Price/Sales | 4.64 | 3.03 | 2.34 |
Price/Cash Flow | 44.99 | 22.21 | — |
Price/Earnings
540222
533573
506690
Financial Strength
|
Metric
|
540222
|
533573
|
506690
|
|---|---|---|---|
Quick Ratio | 0.58 | 0.83 | 1.24 |
Current Ratio | 1.23 | 2.12 | 2.77 |
Interest Coverage | 2.29 | 12.24 | 1.73 |
Quick Ratio
540222
533573
506690
Profitability
|
Metric
|
540222
|
533573
|
506690
|
|---|---|---|---|
Return on Assets (Normalized) | — | 9.08% | — |
Return on Equity (Normalized) | — | 12.69% | — |
Return on Invested Capital (Normalized) | — | 12.04% | — |
Return on Assets
540222
533573
506690
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Sjzsjymvl | Mvyhgk | $79.9 Bil | |
ZTS
| Zoetis Inc Class A | Jtmgjfvgd | Kzxm | $79.3 Bil | |
HLN
| Haleon PLC ADR | Mypxlfwy | Jblwq | $38.1 Bil | |
VTRS
| Viatris Inc | Tnwmjfgw | Kzd | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Rvsbxzcrx | Qxxm | $11.7 Bil | |
CTLT
| Catalent Inc | Qznpwnll | Kvmxtj | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Byqfllb | Mdnc | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Vgfwygkb | Tnvp | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Fgnsxbpxc | Tmrccy | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Hyrshyfqb | Qhrzn | $3.1 Bil |